1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Green Dot stockholders approved the merger with CommerceOne Financial and the separation agreement at a June 23, 2026 special meeting, with more than 99% of votes cast in favor of each. Under the proposed transaction, CommerceOne would acquire Green Dot Bank and Smith Ventures would acquire Green Dot's non-bank fintech operations, and completion is expected in the third quarter of 2026 subject to regulatory approvals.
Merger proposal: 40,869,891 votes for, 139,918 against, 52,234 abstentions; more than 99% of votes cast were in favor.
Separation proposal: 40,709,555 votes for, 300,237 against, 52,251 abstentions; more than 99% of votes cast were in favor.
Advisory vote on transaction-related executive compensation: 35,353,034 for, 4,957,445 against, 751,564 abstentions; not a condition to completion.
Quorum of 72.44% was reached with 41,062,043 of 56,682,705 shares present; completion is expected in Q3 2026 pending regulatory approvals from the Federal Reserve, Alabama State Banking Department and Utah Department of Financial Institutio
Provident Financial Services said Adriano Duarte, its Executive Vice President and Chief Accounting Officer, will become Executive Vice President and Chief Financial Officer effective July 1, 2026, succeeding Thomas Lyons, who retired. Duarte will lead the finance organization, including accounting, treasury, investor relations, and financial risk management, and will continue as Chief Accounting Officer. The filing also reports that director James P. Dunigan retired from the Board on June 18, 2026.
Adriano Duarte named EVP and Chief Financial Officer effective July 1, 2026, and will also keep the Chief Accounting Officer role
Duarte joined Provident in 2020 through the acquisition of SB One Bank and previously served as CFO of SB One Bank
Thomas Lyons, who held the CFO role, retired after more than two decades with Provident
Director James P. Dunigan retired from the Board on June 18, 2026, after more than eight years of service
Sensient Technologies entered a Credit Agreement on June 18, 2026, providing an unsecured delayed-draw term loan of up to $400 million, drawable in up to five advances over fifteen months. Proceeds will refinance existing debt and fund working capital and general corporate purposes. The filing also sets covenants requiring a net leverage ratio of no more than 3.50 to 1.00 and an interest coverage ratio of at least 3.00 to 1.00.
Facility: unsecured delayed-draw term loan of up to $400 million, drawn in up to five advances over fifteen months after closing
Maturity: all amounts due five years from the closing date
Pricing: Term SOFR or Daily Simple SOFR plus 1.625%-2.000%, or Base Rate plus 0.625%-1.000%, depending on Net Leverage Ratio
Covenants: net leverage ratio of no more than 3.50 to 1.00 and interest coverage ratio of at least 3.00 to 1.00; CoBank, ACB is administrative agent
On June 23, 2026, subsidiary Alclear Holdings, LLC signed Amendment No. 4 to its March 31, 2020 credit agreement with JPMorgan Chase Bank, N.A. as administrative agent. The amendment lowers borrowing costs, extends the facility's maturity from June 28, 2026 to June 23, 2031, and changes lender commitments and the letter of credit sublimit.
Lender commitments reduced from $100 million; the filing lists the new amount as '$50,000,0000', which appears to be a typo for $50 million
Letter of credit sublimit raised from $35 million to $50 million
Term SOFR margin cut from 2.50% to 1.50%, base rate margin from 1.50% to 0.50%, and unused commitment fee from 0.35% to 0.25%
Maturity extended from June 28, 2026 to June 23, 2031
Upwork and its domestic subsidiaries entered into a Credit Agreement on June 23, 2026, with Bank of America, N.A. as administrative agent, providing a secured revolving loan of up to $150.0 million. The facility is secured by substantially all company and domestic subsidiary assets and can be increased by up to an additional $50.0 million, and proceeds may be used partly to repurchase or repay certain existing convertible indebtedness.
Revolving facility of up to $150.0 million, including a $10.0 million sublimit for standby letters of credit
Optional increase of up to an additional $50.0 million through a revolver increase or new term loans
Borrowings bear interest at Term SOFR plus 2.00% to 2.50%, or Base Rate plus 1.00% to 1.50%, based on consolidated net leverage
Facility matures June 23, 2029 and contains customary covenants and events of default
Cerebras Systems reported GAAP revenue of $193.4 million for the quarter ended March 31, 2026, up 94% from a year earlier, and a net loss of $14.0 million, down from $23.9 million. The company also gave core revenue guidance of approximately $194.0 million for the second quarter and $855.0 to $865.0 million for fiscal 2026, but its guided core gross margin of 36% to 38% for the second quarter is below the 47% it reported for the first quarter.
GAAP revenue of $193.4 million, up 94% year over year; hardware revenue $110.6 million, cloud and other services revenue $82.8 million
GAAP net loss of $14.0 million, or $0.22 per share, compared with a net loss of $23.9 million, or $0.46 per share, a year earlier
Q2 2026 core revenue outlook of approximately $194.0 million, up 88% year over year, with a core gross margin of 36% to 38%
Full-year fiscal 2026 core revenue outlook of $855.0 to $865.0 million, with a core gross margin of 38% to 41%
International Flavors & Fragrances entered a $1,000,000,000 senior unsecured delayed draw term loan with Wells Fargo as administrative agent, to be used with cash on hand to refinance its €800 million 1.800% Senior Notes due September 25, 2026. The loan must be prepaid from net proceeds of the planned sale of its Food Ingredients business, expected to generate approximately $3.8 billion, which is expected to close by the end of the second quarter of 2027.
$1,000,000,000 single-draw term loan available through September 25, 2026, maturing December 31, 2027
Proceeds, with cash on hand, to refinance €800 million 1.800% Senior Notes due September 25, 2026
Interest at Term SOFR plus 0.875% to 1.500%, based on public debt ratings; no commitment fee
Mandatory prepayment with 100% of net cash proceeds from a Food Ingredients business sale, expected at approximately $3.8 billion
Hayward Holdings and its US and Canadian subsidiaries signed an amended and restated first lien credit agreement with Bank of America, N.A. on June 23, 2026. The agreement refinances the companies' existing term loan and revolving credit facilities in full and extends their maturities, without increasing total indebtedness.
US Borrower Hayward Industries borrowed $960 million of new seven-year U.S. dollar term loans.
A $425 million five-year revolving facility includes a $100 million letter of credit sublimit and a $50 million swingline sublimit.
Term loans bear interest at term SOFR plus 2.00% or the alternate base rate plus 1.00%; the facilities are guaranteed and secured by substantially all assets of the borrowers and guarantors.
The credit agreement includes a change of control event of default, and the revolver carries maximum total leverage and minimum net interest coverage covenants.
NNN REIT entered into amendments to its term loan and revolving credit agreements with Wells Fargo as administrative agent. The company exercised a $200 million incremental option, raising its senior unsecured term loan to $500 million, and lowered the SOFR-based margins on its term loan and revolver based on its current credit ratings. The filing says proceeds will fund general corporate purposes, and the added borrowing and lower pricing are the key changes for shareholders.
Term loan facility increased by $200 million to $500 million; matures February 15, 2029, with two one-year extension options
Term loan SOFR margin lowered to 0.800% from 0.850%; revolver margin lowered to 0.725% from 0.775%
Company entered a $100 million forward starting swap fixing SOFR at 3.43% through February 15, 2029
Amendments dated June 23, 2026; proceeds expected for general corporate purposes
RPC, Inc. (NYSE: RES) said CEO and director Ben M. Palmer will retire, with his exit taking effect on the earlier of a successor being named or December 31, 2026. He will then serve in an advisory role to support the leadership transition, and the board has begun a search for a new CEO that it expects to conclude before the end of 2026.
Ben M. Palmer notified the company of his retirement on June 16, 2026, and will step down as Director, President and CEO.
Effective date is the earlier of a successor being named or December 31, 2026; advisory terms have not been determined.
The board will engage an independent executive search firm; the company said the search is expected to conclude before the end of 2026.
Palmer has served as President and CEO since 2022 and was CFO and Treasurer from 1996 for more than two decades.
ConocoPhillips said its Senior Vice President, Legal, General Counsel and Corporate Secretary, Kelly B. Rose, will retire effective September 1, 2026. The company said her replacement will be announced at a later time, so the company's top legal role will be filled by a successor not yet named.
Kelly B. Rose announced her retirement on June 23, 2026.
Retirement is effective September 1, 2026.
Her replacement has not been named; the company says it will be announced later.
The filing reports no financial results or compensation terms.
Sharplink sold 10,013,351 shares of common stock, with accompanying warrants, to an institutional investor at a combined price of $7.49 per share, for gross proceeds of about $75 million before fees and expenses. The offering closed on June 23, 2026, and the company intends to use the net proceeds to acquire Ether and for general working capital, including share repurchases. The filing states the price was a 41% premium to the June 18, 2026 closing share price of $5.29, and the new shares and warrants add potential dilution for existing shareholders.
10,013,351 shares sold at a combined price of $7.49 per share with warrants; gross proceeds of about $75 million before placement agent fees and offering expenses
Warrants for 10,013,351 shares at an exercise price of $8.15 per share, immediately exercisable and expiring four years from issuance; full exercise would bring about $81.6 million
Placement agent A.G.P./Alliance Global Partners receives a cash fee of 2.0% of gross proceeds
Offering closed June 23, 2026; price was a 41% premium to the $5.29 closing share price on June 18, 2026
NIKE said David Denton, currently CFO of Pfizer, will become Executive Vice President and Chief Financial Officer, replacing Matthew Friend, effective in August 2026. The company also said its fourth quarter fiscal 2026 results, due June 30, will include a one-time tariff refund benefit that was not in its previous guidance; excluding that benefit, results are expected to be generally in line with guidance.
Denton takes over as CFO effective August 16, 2026 per the 8-K; the press release says August 17
Friend becomes an advisor to the CEO and stays with NIKE through his separation on September 4, 2026, with a $2.0 million lump sum transition benefit subject to conditions
Denton's offer includes a $1.45 million base salary, a $11.5 million annual target long-term incentive award, and a $7.25 million new hire cash award
Fourth quarter fiscal 2026 results, reported June 30, include a tariff refund benefit not in prior guidance; excluding it, results are expected to be generally in line
Worthington Enterprises reported fiscal 2026 fourth-quarter net sales of $371.5 million, up 17%, and GAAP diluted EPS of $0.97 versus $0.08 a year earlier, a period that included a $50.8 million impairment. Adjusted diluted EPS fell to $0.97 from $1.06, while full-year net sales rose 20% to $1.4 billion and adjusted diluted EPS rose to $3.37 from $3.09. The company also declared a $0.20 quarterly dividend and appointed W. Bradley Southern as a director.
Q4 net sales $371.5 million, up 17%; GAAP diluted EPS $0.97 vs $0.08; adjusted diluted EPS $0.97 vs $1.06
Full-year net sales $1.4 billion, up 20%; GAAP diluted EPS $3.14 vs $1.92; adjusted diluted EPS $3.37 vs $3.09
Quarterly dividend of $0.20 per share, payable September 29, 2026, to holders of record on September 15, 2026
Former Louisiana-Pacific CEO W. Bradley Southern appointed director; board plans to reduce authorized directors to 11 as three directors retire
KB Home reported second-quarter results for the three months ended May 31, 2026, with revenues down 27% from a year earlier to $1.11 billion and net income falling to $27.3 million from $107.9 million. Diluted earnings per share were $0.43 versus $1.50, and the homebuilding operating income margin dropped to 2.5% from 8.6%. Management said results met or exceeded the midpoint of its key guidance ranges, and the company issued third-quarter and full-year 2026 guidance and repurchased $75.0 million of common stock in the quarter.
Revenues were $1.11 billion, down 27%; homes delivered fell 23% to 2,395.
Net income was $27.3 million versus $107.9 million; diluted EPS was $0.43 versus $1.50.
Housing gross profit margin was 15.2% versus 19.3%, reflecting price reductions and higher relative land costs.
Third-quarter guidance calls for 2,600 to 2,800 deliveries; full-year housing revenues are guided to $4.90 billion to $5.30 billion.
PG&E Corporation and Pacific Gas and Electric Company amended their credit agreements on June 22, 2026. The utility facility's maturity was extended to June 20, 2031, and lender commitments rose from $5.4 billion to $6.25 billion, while the parent facility's maturity moved to June 22, 2029 and gained collateral release terms.
Utility revolving credit commitments increased from $5.4 billion to $6.25 billion, with maturity extended to June 20, 2031
Parent company facility, administered by JPMorgan Chase Bank, N.A., extended to June 22, 2029
Parent facility lien is released if PG&E Corporation holds investment grade ratings from at least two agencies, has no Event of Default, and has no more than $250 million of secured debt, and is reinstated if those conditions fail
Both facilities' interest rate and commitment fee pricing grids were modified
FedEx reported fiscal fourth-quarter revenue of $25.0 billion, up from $22.2 billion a year earlier, and adjusted diluted EPS of $6.31, up from $6.07. GAAP diluted EPS fell to $6.60 from $6.88, mainly due to FedEx Freight spin-off costs, business optimization costs and other adjustments. The filing also completed the June 1, 2026 FedEx Freight spin-off and gave a calendar 2026 outlook of about 11% revenue growth and GAAP diluted EPS of $16.55 to $17.75.
Q4 revenue $25.0 billion vs. $22.2 billion a year earlier; GAAP operating income $1.55 billion vs. $1.79 billion
Q4 adjusted diluted EPS $6.31 vs. $6.07; GAAP diluted EPS $6.60 vs. $6.88
Calendar 2026 forecast: revenue growth about 11%, GAAP diluted EPS $16.55 to $17.75, adjusted $16.90 to $18.10; plans to repurchase up to $1 billion of shares
On June 23, 2026, Chief Medical Officer William Go left Janux Therapeutics. The company determined the departure was a termination without Cause under its Change in Control and Severance Benefit Plan. Janux has started a search for a successor, and existing clinical leaders will cover his responsibilities in the interim, with the company saying its development strategy, regulatory plans and previously disclosed clinical timelines are unaffected.
Departure of William Go, M.D., Ph.D., as Chief Medical Officer effective June 23, 2026
Company classified the exit as a termination without Cause under its Change in Control and Severance Benefit Plan
Search for a successor has begun; members of the existing clinical leadership team are assuming his duties in the interim
Company states the departure was not the result of any disagreement on operations, policies or practices
Fastenal entered into a Second Amended and Restated Credit Agreement with Wells Fargo as administrative agent on June 18, 2026, renewing its unsecured revolving credit commitment at $835 million and extending maturity to June 18, 2031. The company also amended its Master Note Agreement, reducing the maximum notes outstanding from $900 million to $600 million. Both deals replace the consolidated EBITDA covenant with interest coverage and leverage ratio covenants, which matters to shareholders because it changes the terms under which the company can borrow.
Revolving credit commitment renewed at $835 million; accordion option increased from $365 million to up to $500 million, for a possible total of $1.335 billion
Revolving credit maturity extended to June 18, 2031, with two one-year extension options
Master Note Agreement maximum reduced from $900 million to $600 million; issuance period extended to June 18, 2031
New covenants require minimum interest coverage of 3.00 to 1.00 and maximum total leverage of 3.00 to 1.00, stepping up to 3.50 to 1.00 after qualified acquisitions of at least $750 million
At its June 16, 2026 annual meeting, IDEAYA Biosciences stockholders elected three Class I directors, ratified PricewaterhouseCoopers LLP as auditor for 2026, and approved executive compensation in a non-binding vote. The same day, the board named Yujiro S. Hata chairman and Terry Rosen, Ph.D., lead independent director, which sets the board's leadership structure.
Yujiro S. Hata received 70,546,418 votes for and 2,470,077 withheld; M. Garret Hampton, Ph.D., received 56,718,637 for and 16,297,858 withheld
PricewaterhouseCoopers LLP ratified: 82,579,758 for, 141,240 against, 384,840 abstentions
Advisory say-on-pay vote: 64,269,756 for, 8,349,131 against, 397,608 abstentions
Effective June 16, 2026, Hata became Chairman and Terry Rosen, Ph.D., became Lead Independent Director
QuidelOrtho appointed Micah Young, former CFO of Masimo, as Chief Financial Officer effective July 6, 2026, succeeding Joseph Busky, who is retiring. Busky will stay in a transition role and then serve as a special advisor to the CEO for up to 24 months. The filing discloses Young's pay package, including a $750,000 base salary and a $6,500,000 inducement RSU grant, which shareholders may track in future proxy and 10-K disclosures.
Micah Young, 48, becomes CFO effective July 6, 2026, after serving as CFO of Masimo from October 2017 until Masimo's acquisition by Danaher in June 2026
Young's offer letter sets a $750,000 base salary, a 100% target bonus, a $500,000 cash sign-on bonus and $6,500,000 in inducement RSUs vesting over three years
Joseph Busky, who announced his retirement in February 2026, will be paid a $340,000 annual base salary for six months after the effective date, then $100,000 as a special advisor for up to 24 months
FMC and certain subsidiaries entered into Amendment No. 7 to their Fifth Amended and Restated Credit Agreement on June 16, 2026, with Citibank, N.A. as administrative agent. The amendment changes the limitation on liens and releases security interests on certain collateral that previously secured obligations under the credit agreement. The filing does not state the size of the facility or any change in borrowing amounts, so the financial effect for shareholders is not quantified.
Amendment No. 7 dated June 16, 2026, to the credit agreement originally dated June 17, 2022
Amendment changes the limitation on liens and releases security interests on certain previously pledged collateral
Citibank, N.A. serves as administrative agent; some lenders also provide cash management, investment banking, trust, leasing, interest rate and foreign exchange services to FMC
On June 23, 2026, Fiserv completed the issuance of €500 million of 3.750% senior notes due 2030 and €500 million of 4.250% senior notes due 2034, adding €1 billion of new debt. The filing describes the notes' terms but does not state how the proceeds will be used.
€500 million 3.750% notes mature October 15, 2030, with annual interest starting October 15, 2026
€500 million 4.250% notes mature June 23, 2034, with annual interest starting June 23, 2027
Holders can require repurchase at 101% of principal plus accrued interest upon a change of control triggering event
Notes were issued under a 2007 indenture with U.S. Bank Trust Company, National Association, as trustee
All In FutureTech Alliance replaced its chief executive and chairman on June 17, 2026. Li Yangyang stepped down as CEO and Chairman but remains President and a Class A director, and the board named Weizhi (Eric) Shao CEO and Li Shanglong chairman. The filing says Shao's compensation is still being negotiated and will be disclosed later, so shareholders do not yet know its terms.
Li Yangyang resigned as CEO and Chairman effective June 17, 2026, and stays on as President and a Class A director
Weizhi (Eric) Shao, 40, appointed CEO effective June 17, 2026; his compensation terms are still being negotiated
Li Shanglong appointed director and Chairman effective June 17, 2026; he will receive US$1 per year and is deemed independent under Nasdaq standards
The company says Li Yangyang's departure was not the result of any disagreement on operations, policies, or practices
Translational Development Acquisition Corp. (TDAC) reported the results of redemptions tied to its June 17, 2026 shareholder vote on extending its deadline to complete an initial business combination. Public shareholders redeemed 2,598,697 Class A shares, and holders of 14,651,303 shares chose to keep them, leaving about $156.8 million in the trust account. The vote concerns TDAC's proposed business combination with ProLogium Holding Inc.
Public shareholders redeemed 2,598,697 Class A shares; holders of 14,651,303 shares continued to hold them.
About $156.8 million remains in the trust account after redemptions.
The press release states that 95% of the shares voted were in favor of the extension.
TDAC announced a merger agreement with ProLogium on May 27, 2026; the filing cites a $250 million Minimum Cash condition to closing.
Carnival reported second-quarter 2026 revenue of $6.66 billion, up from $6.33 billion a year earlier, and adjusted net income of $569 million, up from $470 million. Net income attributable to the company fell to $537 million from $565 million, and diluted EPS was $0.39 versus $0.42, as fuel prices rose nearly 30%. The company has repurchased over $450 million of stock under its current buyback program, and the filing says fuel and currency changes lowered its June full-year guidance versus prior guidance by less than $0.01 per share.
Q2 2026 total revenues $6.663 billion vs. $6.328 billion; net income attributable to Carnival $537 million vs. $565 million.
Adjusted EPS $0.41 vs. $0.35 a year earlier; diluted EPS $0.39 vs. $0.42.
Full-year 2026 guidance: adjusted EPS approximately $2.22; net yields up approximately 3.2% in current dollars.
Over $450 million of stock repurchased to date; $207 million in dividends paid during the quarter.
Wendy's appointed Steve Cirulis as Chief Financial Officer and Chief Strategy Officer effective June 23, 2026, replacing Ken Cook, whose employment the board terminated without cause effective July 31, 2026. Cook will remain in an advisory role through July, and the company says he will receive 24 months of salary continuation. A CFO change is a significant leadership transition for shareholders, though the filing contains no financial results.
Steven W. Cirulis, age 55, becomes CFO and Chief Strategy Officer effective June 23, 2026; the board approved the appointment June 19, 2026
Cirulis' employment letter sets a base salary of $675,000 and a target bonus of 90% of base salary, with a payout range of zero to 200% of target
Initial annualized long-term incentive grant target fair value is $1,650,000
Ken Cook's employment was terminated without cause effective July 31, 2026, with 24 months of salary continuation instead of 12
Boundless Bio agreed on June 22, 2026 to an all-stock merger with privately held Serapha Bio, a clinical-stage company developing an in vivo base editing therapy for Alpha-1 Antitrypsin Deficiency. Boundless stockholders are expected to own about 3.69% of the combined company, and the company's CEO, Zachary Hornby, steps down effective July 1, 2026, which affects shareholders' stake and the company's management.
Merger agreement dated June 22, 2026; the combined company is expected to operate as Serapha Bio and trade as AATD, subject to Nasdaq approval
Pre-merger Boundless holders expected to own about 3.69% and Serapha holders about 96.31% of the combined company, fully diluted
Boundless may pay a pre-closing cash dividend; the press release says about $44 to $48 million, and the press release states the BBI-940 program will not be advanced
CEO Zachary Hornby steps down July 1, 2026; Chief Legal Officer Jessica Oien to serve as principal executive officer; closing expected in Q4 2026
Office Properties Income Trust (OPI) emerged from chapter 11 on June 17, 2026, and RMR LLC, RMR Group's majority-owned subsidiary, entered into amended business and property management agreements with OPI. The filing sets a five-year initial term, a $14.0 million annual business management fee for the first two years, and equity issuances to RMR LLC that could reach 10% of OPI's common equity.
OPI's Plan became effective June 17, 2026, after confirmation by the Bankruptcy Court on April 22, 2026.
Amended business management agreement pays RMR LLC $14.0 million a year for the first two years.
RMR LLC receives OPI common shares equal to 2% of common equity on the Effective Date, plus up to 8% more upon meeting metrics set by OPI's board.
Galectin Therapeutics said its Type C meeting with the FDA produced agreement on the primary endpoint and regulatory path for a potential full approval of belapectin in patients with MASH cirrhosis and portal hypertension. The company plans to file the Phase 3 protocol in the third quarter of 2026 and is exploring strategic and financial partnerships to support development.
FDA agreed to a composite liver outcome primary endpoint that includes prevention of large esophageal varices (>5 mm)
FDA accepted the company's proposed blinded central review process for endoscopic assessments, based on the NAVIGATE trial approach
Company plans a single 2 mg dose in the Phase 3 trial and expects a trial size generally comparable to NAVIGATE
Phase 3 protocol submission anticipated in the third quarter of 2026; company is actively pursuing partners
FMC Corporation signed a framework agreement on June 18, 2026, to sell underutilized buildings and land at its Stine Research Center campus in Newark, Delaware, to Ercor Elkton, LLC, for gross cash proceeds of approximately $114 million. FMC expects to use the proceeds to pay down debt and says research operations will continue at the site, but the agreement is preliminary and may not result in a completed transaction.
Gross cash proceeds of approximately $114 million from the sale to Ercor Elkton, LLC, subject to due diligence and other conditions and adjustments
Agreement dated June 18, 2026; closing is expected in the fourth quarter, and FMC plans to negotiate a leaseback for facilities it actively operates
FMC expects the proceeds to be used to pay down debt and says its Stine Research Center will continue to operate at the site
FMC retains ownership of the adjacent Maryland property; the filing states there can be no assurance the agreement will result in a transaction
Korn Ferry reported fourth-quarter fiscal 2026 fee revenue of $759.8 million, up 7% year over year, and diluted earnings per share of $1.39, up from $1.21. For the full year, diluted EPS was $5.22 versus $4.60 in fiscal 2025, and the company guided first-quarter fiscal 2027 fee revenue to $725 million to $745 million. Improved revenue and profit are the main points for shareholders, though the guidance assumes no material negative impact from the recent Middle East conflict.
Q4 fiscal 2026 fee revenue was $759.8 million, up 7% (5% at constant currency); net income attributable to Korn Ferry was $73.1 million versus $64.2 million
Full-year fiscal 2026 diluted EPS was $5.22 versus $4.60; adjusted diluted EPS was $5.28 versus $4.88
Q1 fiscal 2027 outlook: fee revenue of $725 million to $745 million and diluted EPS of $1.32 to $1.38
Company repurchased 1,240,458 shares for $78.8 million and paid $28.3 million in dividends during the quarter
Accenture said it increased its fiscal 2026 share repurchase program by $2 billion, to $7.5 billion in expected repurchases, with all purchases to be completed by August 31, 2026. The company said total planned fiscal 2026 shareholder returns, including dividends, are expected to reach $11.5 billion, and that roughly $1 billion of repurchase capacity would remain under the existing authorization afterward.
Total expected fiscal 2026 share repurchases rise to $7.5 billion, a 62% increase year-over-year
Expected fourth-quarter repurchases total $2.3 billion, including the $2 billion increase and $300 million previously planned
Year-to-date shareholder returns through dividends and buybacks were $8.2 billion; planned fiscal 2026 total is $11.5 billion
Repurchases are to be completed by August 31, 2026; the company will request new Board authorization in September 2026
Paramount Gold Nevada Corp. furnished a June 17, 2026 press release and a technical report summary for its 100%-owned Sleeper Gold Project in Nevada, which is an Initial Assessment under S-K 1300 rules. The study estimates an after-tax net present value of $402 million at an assumed gold price of $3,600 per ounce, rising to $867 million at $4,700 per ounce, and it recommends an $8.7 million advancement program before a pre-feasibility study. For shareholders, the filing sets out the project's economic estimates and updated resource figures, but these depend on assumed metal prices and the study is preliminary.
Base case after-tax NPV (8%) of $402 million at $3,600 per ounce gold; upside case $867 million at $4,700 per ounce gold
Initial capital of $201 million and payback period of about 1.4 years in the base case
Estimated 17-year mine life with about 1.1 million ounces of total payable gold production
Inferred Mineral Resources of 2.30 million ounces of gold, versus 1.21 million ounces in the 2023 estimate; recommended advancement program of $8.7 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.